BlackRock, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$11.47B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BLK stock price vs BXP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BXP's multiple
Needs BXP P/E.
Implied fair value · at BLK's multiple
Needs BLK P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BlackRock, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
BXP, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
STATE STREET CORP
BLK vs STT
NORTHERN TRUST CORP
BLK vs NTRS
PRICE T ROWE GROUP INC
BLK vs TROW
The Goldman Sachs Group, Inc.
BLK vs GS
Morgan Stanley
BLK vs MS
Blackstone Inc.
BLK vs BX
COSTAR GROUP, INC.
BLK vs CSGP
WELLTOWER INC.
BLK vs WELL
UDR, Inc.
BLK vs UDR
Prologis, Inc.
BLK vs PLD
Public Storage
BLK vs PSA
EQUITY RESIDENTIAL
BLK vs EQR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe BLK can sustain 18.7% revenue growth and 22.9% net margin while the market continues to value it on earnings rather than revenue, then hold or add modestly because BLK looks cheaper than BXP on P/E and has much lower leverage; if you focus on DCF and weak quality signals, then be cautious because BLK trades well above the DCF range and has a Piotroski F-Score of 3/9.
On a BXP basis, BLK’s current price of $1090.39 sits below the implied P/E price of $1422.95, suggesting 30.5% upside. However, that relative upside coexists with a valuation that is already rich versus its own historical band and far above the DCF range.
Supporting Metrics